Form 4 for SYF Synchrony Financial
Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-01 · accession 0001601712-25-000107 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-04 | 2025-03-03 | SYF | Juel Carol | See remarks | S - Sale+OE | $59.19 | -91.4K | 123.6K | -43% | -$5.41M |
| DM | 2025-03-04 | 2025-03-03 | SYF | Juel Carol | See remarks | M - OptEx | $33.90 | +34.8K | 131.0K | +36% | +$1.18M |
| D | 2025-03-04 | 2025-03-01 | SYF | Juel Carol | See remarks | F - Tax | $60.68 | -15.5K | 114.4K | -12% | -$941.6K |
| D | 2025-03-04 | 2025-03-01 | SYF | Juel Carol | See remarks | A - Grant | $60.68 | +24.1K | 129.9K | +23% | +$1.46M |
| DM | 2025-03-04 | 2025-03-03 | SYF | Juel Carol | See remarks | M - OptEx | $0.00 | -34.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | S | D | 19,404 | $60.49 | 58,113 | D | — | — | (F3) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2024. (F7) This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.96 to $60.93. Information regarding the number of shares sold at each price will be provided upon request. |
| 2 | Common | Common Stock | 2025-03-03 | S | D | 46,102 | $59.29 | 77,517 | D | — | — | (F3) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2024. (F6) This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.96 to $59.95. Information regarding the number of shares sold at each price will be provided upon request. |
| 3 | Common | Common Stock | 2025-03-03 | S | D | 13,177 | $57.43 | 135,986 | D | — | — | (F3) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2024. (F4) This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.96 to $57.87. Information regarding the number of shares sold at each price will be provided upon request. |
| 4 | Common | Common Stock | 2025-03-03 | M | A | 18,145 | $33.53 | 149,163 | D | — | — | (F3) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2024. |
| 5 | Common | Common Stock | 2025-03-03 | M | A | 16,613 | $34.30 | 131,018 | D | — | — | (F3) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2024. |
| 6 | Common | Common Stock | 2025-03-01 | F | D | 15,518 | $60.68 | 114,405 | D | — | — | (F2) Reflects the number of shares of Company common stock automatically withheld by the Company to pay the tax liability of the reporting person in connection with the vesting of restricted stock units. No investment decision was made by the reporting person in connection with the withholding. |
| 7 | Common | Common Stock | 2025-03-03 | S | D | 363 | $61.13 | 57,750 | D | — | — | (F3) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2024. (F8) This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.05 to $61.19. Information regarding the number of shares sold at each price will be provided upon request. |
| 8 | Common | Common Stock | 2025-03-01 | A | A | 24,102 | $60.68 | 129,923 | D | — | — | (F1) Represents restricted stock units that will vest in three equal annual installments of 33.33% each, beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial (the "Company") common stock. |
| 9 | Common | Common Stock | 2025-03-03 | S | D | 12,367 | $58.57 | 123,619 | D | — | — | (F3) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2024. (F5) This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.98 to $58.92. Information regarding the number of shares sold at each price will be provided upon request. |
| 10 | Derivative | Employee Stock Option (right to buy) | 2025-03-03 | M | D | 16,613 | $0.00 | 0 | D | $34.30 · — to 2027-04-01 | 16,613 Common Stock | (F3) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2024. (F9) The reporting person was awarded employee stock options on April 1, 2017, which vest in five equal annual installments of 20% each, beginning on the first anniversary of the grant date. |
| 11 | Derivative | Employee Stock Option (right to buy) | 2025-03-03 | M | D | 18,145 | $0.00 | 0 | D | $33.53 · — to 2028-04-01 | 18,145 Common Stock | (F3) This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2024. (F10) The reporting person was awarded employee stock options on April 1, 2018, which vest in five equal annual installments of 20% each, beginning on the first anniversary of the grant date. |